A Trial of AK112 (PD1/VEGF Bispecific) in Combination With Chemotherapy in Patients With NSCLC
Clinical trial NCT04736823 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04736823
- Sponsor
- Akeso
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-02-01
- Primary completion
- 2026-07-01
- Enrollment
- 265
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.